Artificial Disc Market: By Product Type (Cervical disc, Lumbar disc), By Material Type (Metal on metal, Metal on the biopolymer), By End User (Hospitals, Orthopaedic Clinics, Ambulatory surgical centers), and Geography  

Artificial Disc Market size was valued at USD 1.1 billion in 2022 and is expected to grow at a CAGR of 18.9% from 2023-2029. The disc is a soft cushioning-like structure located in between the bones of the spine, known as the “vertebra.”  The disc is made up of cartilage-like tissue and contains an inner portion, a nucleus, and an outer portion called an annulus. In the majority of cases, the disc is flexible enough to allow the spine to bend. Artificial discs are synthetic replacements for damaged intervertebral discs present in the lumbar and cervical regions of the spine. In artificial disc surgery, worn or damaged disk material between the small bones in the spine (vertebrae) is removed and replaced with a synthetic or "artificial" disc. Artificial disc surgery is performed on the lower back or lumbar spine and the neck or cervical spine. The artificial discs are designed with the goal of resembling the form and function of the spine’s natural disc. The artificial disc market is in the developing stage. Launch of new products, technological development, collaborations, acquisitions, and mergers are the key strategies followed by various medical device companies to increase revenue share in the global artificial disc market.

Artificial Disc Market Key Developments:

• In 2013, Zimmer Biotech acquired LDR holdings to launch Mobi-C in the U.S. cervical market. Similarly,
• in September 2012, Globus Medical, Inc. announced that the Food and Drug Administration (FDA) has granted premarket approval for the Secure-C cervical artificial disc. The technological developments in the artificial discs enabled better translational and rotational movements, stability of implant for a long time, minimally invasive surgery and improvement in Quality adjusted life year.
• In September 2016, Medtronic, Zimmer Biomet enters into 2-level cervical disc and robotic surgery markets. In June 2015, Aesculap received U.S. FDA approval for the activL artificial disc for one level lumbar use.